Milestone Pharmaceuticals Inc.
Income Statement
| Line Item | FY2018 |
|---|---|
| Revenue | — |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $16.8M |
| SG&A Expense | $3.1M |
| Operating Income | $-23.8M |
| Operating Margin | — |
| Interest Expense | — |
| Pretax Income | $-23.1M |
| Income Tax Expense | $74.0K |
| Net Income | $-23.2M |
| Net Margin | — |
| EPS (Basic) | $72.63 |
| EPS (Diluted) | $72.63 |
| Shares Outstanding (Basic) | 596.8K |
| Shares Outstanding (Diluted) | 596.8K |
| Dividends Per Share | — |